what is microdosing of glp-1 THE PCCA BLOG | Microdosing

Anti-liraglutide antibodies were detected in 42 (2.8%) of 1505 SAXENDA-treated adult patients with a post-baseline assessment

Glucose-lowering agents that reduce the risk of major cardiovascular events would be considered a major advance, as recently reported with liraglutide and semaglutide, 2 glucagon-like peptide-1 receptor agonists, and with empagliflozin and canagliflozin, 2 SGLT-2 (sodium-glucose cotransporter type 2) inhibitors, but not with DPP-4 (dipeptidyl peptidase-4) inhibitors

10.2337/diabetes.54.6.1615 10 ByndlossM.DevkotaS.DucaF.NiessJ

Glutathione Measurement In the first step, adding the DTNB and fluorescent or colorimetric substrate measures the free GSH in the samples

The procedure takes less than 10 minutes

doi:10.1056/NEJMoa1603827 98